- Home
- LSPD vs VCEL Comparison
LSPD vs VCEL Comparison
Compare LSPD & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSPD | VCEL |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.0B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | LSPD | VCEL |
|---|---|---|
| Price | $12.47 | $37.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 5 |
| Target Price | $13.63 | ★ $57.50 |
| AVG Volume (30 Days) | 438.6K | ★ 585.5K |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 236.54 |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $1,157,458,000.00 | $258,716,999.00 |
| Revenue This Year | $15.25 | $17.86 |
| Revenue Next Year | $11.85 | $18.55 |
| P/E Ratio | ★ N/A | $156.36 |
| Revenue Growth | ★ 14.24 | 14.05 |
| 52 Week Low | $7.34 | $29.24 |
| 52 Week High | $15.22 | $63.00 |
Technical Indicators
Market Signals| Indicator | LSPD | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 58.91 | 47.20 |
| Support Level | $11.96 | $35.33 |
| Resistance Level | $12.59 | $41.65 |
| Average True Range (ATR) | 0.35 | 1.63 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 86.57 | 27.14 |
Price Performance
Historical ComparisonAbout LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.